搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Heloderma suspectum cinctum Natriuretic and helokinestatin peptides CSB-YP512012HVK
CSB-EP512012HVK
CSB-BP512012HVK
CSB-MP512012HVK
CSB-EP512012HVK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Formation of crista junctions protein 1 (FCJ1), partial CSB-YP512013AZA1
CSB-EP512013AZA1
CSB-BP512013AZA1
CSB-MP512013AZA1
CSB-EP512013AZA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Mitochondrial zinc maintenance protein 1, mitochondrial (MZM1) CSB-YP512014AZA
CSB-EP512014AZA
CSB-BP512014AZA
CSB-MP512014AZA
CSB-EP512014AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Adenylosuccinate synthetase (HCDG_03993) CSB-YP512015AZA
CSB-EP512015AZA
CSB-BP512015AZA
CSB-MP512015AZA
CSB-EP512015AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Leucine aminopeptidase 1 (LAP1) CSB-YP512016AZA
CSB-EP512016AZA
CSB-BP512016AZA
CSB-MP512016AZA
CSB-EP512016AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Fe-S cluster assembly protein DRE2 (DRE2) CSB-YP512017AZA
CSB-EP512017AZA
CSB-BP512017AZA
CSB-MP512017AZA
CSB-EP512017AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Probable Xaa-Pro aminopeptidase P (AMPP), partial CSB-YP512018AZA
CSB-EP512018AZA
CSB-BP512018AZA
CSB-MP512018AZA
CSB-EP512018AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Probable DNA repair protein RAD50 (PFF0285c), partial CSB-YP512019EWP
CSB-EP512019EWP
CSB-BP512019EWP
CSB-MP512019EWP
CSB-EP512019EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microbacterium testaceum N-acyl homoserine lactonase (aiiM) CSB-YP512020MTN
CSB-BP512020MTN
CSB-MP512020MTN
CSB-EP512020MTN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycine max Cyanate hydratase (CYN) CSB-YP512021GGV
CSB-EP512021GGV
CSB-BP512021GGV
CSB-MP512021GGV
CSB-EP512021GGV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycine max CASP-like protein 1, partial CSB-YP512022GGV1
CSB-EP512022GGV1
CSB-BP512022GGV1
CSB-MP512022GGV1
CSB-EP512022GGV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycine max Casparian strip membrane protein 1, partial CSB-YP512023GGV1
CSB-EP512023GGV1
CSB-BP512023GGV1
CSB-MP512023GGV1
CSB-EP512023GGV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative aminoacrylate hydrolase RutD (rutD) CSB-YP512024ENS
CSB-EP512024ENS
CSB-BP512024ENS
CSB-MP512024ENS
CSB-EP512024ENS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli tRNA (uracil (54)-C (5))-methyltransferase CSB-YP512025ENS
CSB-EP512025ENS
CSB-BP512025ENS
CSB-MP512025ENS
CSB-EP512025ENS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O157:H7 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB (rutB) CSB-YP512026EOF
CSB-EP512026EOF
CSB-BP512026EOF
CSB-MP512026EOF
CSB-EP512026EOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O157:H7 Secreted effector protein EspF (U) CSB-YP512027EOF
CSB-EP512027EOF
CSB-BP512027EOF
CSB-MP512027EOF
CSB-EP512027EOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus plantarum Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta 2 (accD2) CSB-YP512028LMT
CSB-EP512028LMT
CSB-BP512028LMT
CSB-MP512028LMT
CSB-EP512028LMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinosynnema mirum Proteasome subunit beta (prcB) CSB-YP512029AXJ
CSB-EP512029AXJ
CSB-BP512029AXJ
CSB-MP512029AXJ
CSB-EP512029AXJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylotenera mobilis Flagellar brake protein YcgR (ycgR) CSB-YP512030MTI
CSB-EP512030MTI
CSB-BP512030MTI
CSB-MP512030MTI
CSB-EP512030MTI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylovorus sp. NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP512031MTK1
CSB-EP512031MTK1
CSB-BP512031MTK1
CSB-MP512031MTK1
CSB-EP512031MTK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>